Malignant Germ Cell Tumours of Ovary

References
1 Williams SD. Current management of ovarian germ cell tumors. Oncology 1994; 8:53-60.
2 Smales E and Pecham MJ. Chemotherapy of germ cell ovarian tumors : First line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer Clin Oncol 1987; 23:469-72.
3 Gershenson DM , Morris M , Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Silva EG and Wharton JT. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncology1990;8:715- 720
4 Williams SD, Blessing JA, Liao Shu-Yuan, Ball H, and Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: A trial of the Gynecologic Oncology Group. J Clin. Oncol 1994;12:701-706.
5 Hitchins RN, Newlands ES , Smith DB, Begent RHJ, Rustin GJS and Bagshawe KD. Long term outcome in patients with germ cell tumours treated with POMB-ACE chemotherapy. Comparision of commonly used classification systems of good and poor prog¬nosis. Brit J Cancer 1989;59:236-242.
6 Dark GG, Bower M, Newlands ES, Paradinas F, and Rustin GJS. Surveillance Policy for stage 1 ovarian germ cell tumors. J Clin Oncol 1997;15:620-624.
7 Loehrer PJ, Einhorn LH and Williams SD. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncology 1986;4:528-36.
8 Brewer M, Gershenson DM, Herzog CE, el al. Outcome and reproductive function after chemotherapy for ova¬rian dysgerminoma. J Clin Oncol 1999;17:2670-2675.
9 Laufer MR. Reproductive issues for cancer patients/sur¬vivors. J Clin Oncol 1999:17:2631-32.
10 Low JH, Perrin LC, Crandon AJ and Hacker NF. Con¬servative surgery to preserve ovarian function in pa¬tients with malignant ovarian germ cell tumors.: A re¬view of 74 cases. Cancer 2000:89:391-8.